SGHT
Sight Sciences, Inc. · Healthcare
Director and 10% owner Staffan Encrantz bought $4.6M of Sight Sciences, Inc.
Bought$4,598,107
$8.33Price
551,802Shares
+12%Stake
What SGHT did for a copier
- $1,000 copied at Wed, May 18 open, $8.95
- $1,133
- S&P 500, same days
- −5.1%
Measured over 30 trading days, to the Jul 1 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −5.3% against the S&P 500, and 3 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, May 13. Filed Tue, May 17, 9:40 PM ET, after the close. Returns use the May 18 open and the Jul 1 close. Not investment advice.